BMS291 Pathophysiology and Pharmacology 1 (8)

CSU Discipline Area: Biomedical Science (BIMSC)

Duration: One session

Abstract:

This subject explores pathophysiological processes contributing to disease. This subject focuses on pathophysiological processes associated with musculoskeletal, cardiovascular and respiratory dysfunction. Relevant pharmacology is integrated throughout.

+ Subject Availability Modes and Locations

Session 1
Internal	Albury-Wodonga
Internal	Bathurst
Internal	Dubbo
Internal	Orange
Internal	Wagga Wagga
Distance *	Orange
Session 2
Distance *	Orange

*This subject offering contains a residential school. Please view following information for further details.

Continuing students should consult the SAL for current offering details: BMS291

Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.

Prerequisite(s):

BMS192 or (BMS130 and MCR101 )

Objectives:

Upon successful completion of this subject, students should:

be able to:
* define common pathophysiological and pharmacological terms;
* describe characteristics and origin of different types of cellular injury;
* demonstrate an understanding of cellular adaptation to injury;
* identify the interaction and relative contribution genetic and environmental factors have on health breakdown;
* describe the characteristics of cancerous cells;
* describe the four pharmacokinetic processes (absorption, distribution, metabolism and elimination);
* outline key pharmacodynamic principles (eg agonist and antagonists, receptor-drug interactions);
* describe the involvement of microorganisms in disease;
* name and describe the actions of the major classes of antimicrobial drugs;
* describe the consequences of alterations in fluids, electrolytes and acid-base balance;
* outline the major haematological pathologies and malignancies;
* describe the pathogenesis of major cardiovascular system dysfunction;
* describe the aetiology and manifestations of shock;
* outline the primary pharmacological interventions used in the treatment of cardiovascular disease;
* describe the pathogenesis of common respiratory dysfunctions;
* describe use of pharmacological agents in the treatment and management of respiratory pathophysiological states;
* describe the major types of musculoskeletal pathology including both mechanical and physiological injuries;
* demonstrate understanding of the origin and main theories of pain; and
* explain the pharmacological treatment of inflammation and pain.

Syllabus:

The subject will cover the following topics:

PATHOPHYSIOOGICAL AND PHARMACOLOGICAL FOUNDATIONS
* Cell injury, adaptation and death
* Pharmacokinetics and pharmacodynamics

GENERAL PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Fluid, electrolyte and acid-base imbalances
* Pain and analgesic agents
* Inflammation and anti-inflammatory agents
* Infectious disease and antimicrobial agents
* Neoplastic disorders and antineoplastic agents

SYSTEMATIC PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Cardiovascular dysfunction (coagulopathy, hypertension, atherosclerosis, dysrhythmias, pump failure) and associated pharmacology
* Respiratory dysfunction (asthma, chronic airways limitation, hypoventilation, pulmonary hypertension) and associated pharmacology
* Musculoskeletal dysfunction (arthritis, osteoporosis, metabolic disorders, muscular dystrophy) and associated pharmacology

Back